La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Panbela Therapeutics a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Panbela Therapeutics..

Panbela Therapeutics (OTC:PBLA) Azioni, Catena delle Opzioni

Panbela Therapeutics

Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine (CPP-1X) and sulindac), and eflornithine (CPP-1X), which provide a multi-targeted approach to reset dysregulated biology present in many types of diseases such as cancer and autoimmunity.

Lake Street analyst Ryan Meyers initiates coverage on Arena Group Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AREN#AMEX">AREN</a>) with a Buy rating and announces Price Target of $10.

News

Price Target

Initiation

Analyst Ratings

AREN

Lake Street Initiates Coverage On Arena Group Holdings with Buy Rating, Announces Price Target of $10

<ul>
<li>TSLA</li>
<li>GLD</li>
<li>GOOGL</li>
<li>BULL</li>
<li>GOOG</li>
<li>UNH</li>
<li>NVDA</li>
<li>RKLB</li>
<li>PLUG</li>
<li>QS</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

Trading Ideas

BULL

GOOG

GOOGL

NVDA

PLUG

RKLB

TSLA

Top 10 Trending Stocks On WallStreetBets As Of July 21, 2025 (Via Swaggy Stocks)

OceanPal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) (the "Company"), a global shipping company specializing in the ownership of vessels, today announced the pricing of its upsized public offering of 10,975,600 units at a public offering price of US$1.64 per unit. Each unit consists of one common share and one warrant to purchase one common share.
Each Warrant will expire three (3) years from the issuance, will be immediately exercisable upon issuance at an initial exercise price equal to 225% of the public offering price, subject to adjustment on the First Reset Date and the Second Reset Date (as defined in the warrants) and subject to a floor price therein. The warrants may also be exercised on a zero cash exercise option pursuant to which the holder may exchange each warrant for two (2) common shares.
Gross proceeds to the Company, before deducting placement agent's fees and other offering expenses, are expected to be approximately US$18.0 million. The offering is expected to close on July 22, 2025, subject to the satisfaction of customary closing conditions.&nbsp;&nbsp;
Maxim Group LLC is acting as sole book-running manager in connection with the offering.

Offerings

OceanPal Prices Upsized $18M Public Offering Of 10.975M Units At $1.64/Unit

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Overweight and raises the price target from $650 to $750.

Morgan Stanley Maintains Overweight on Meta Platforms, Raises Price Target to $750

Barclays analyst Benjamin Budish maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Overweight and raises the price target from $106 to $113.

SCHW

Barclays Maintains Overweight on Charles Schwab, Raises Price Target to $113

Barclays analyst Julian Mitchell maintains 3M (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>) with a Overweight and raises the price target from $170 to $172.

Barclays Maintains Overweight on 3M, Raises Price Target to $172

Barclays analyst David Anderson maintains SLB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Overweight and lowers the price target from $47 to $46.

Barclays Maintains Overweight on SLB, Lowers Price Target to $46

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains WaFd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAFD#NASDAQ">WAFD</a>) with a Market Perform and raises the price target from $30 to $32.

WAFD

Keefe, Bruyette & Woods Maintains Market Perform on WaFd, Raises Price Target to $32

ONAR Holding Corporation (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/ONAR#OTCQB">ONAR</a>), a fast-growing marketing technology company and global network of performance-driven agencies, today announced the appointment of Scott Kauffman, former Chairman and CEO of MDC Partners, as Chairman of its Board of Directors. This strategic move signals a new chapter of accelerated growth, M&amp;A focus, and industry leadership for ONAR.

Management

ONAR

ONAR Holding Appoints Scott Kauffman As Chairman To Drive Growth And M&A Strategy

<ul>
<li>Longeveron has licensed issued US Patent 12,168,028 B2, entitled "Methods for obtaining cardiomyogenic precursor cells" from the University of Miami</li>
<li>New patent protects a method to derive GHRH-Receptor+ cardiomyogenic cells from pluripotent stem cells (PSCs)</li>
<li>New technology substantially advances Longeveron's repertoire of stem cell therapy technologies</li>
<li>Opportunity to expand pipeline in cardiovascular, rare and pediatric disease areas</li>
</ul>
MIAMI, July 21, 2025 (GLOBE NEWSWIRE) -- &nbsp;<a href="https://www.globenewswire.com/Tracker?data=NPkzqeB8EzErF4skuvTqYxNjCVH7pyJ3DMIu-Ts3WZG-zQNdJ5seIHNJrQnGfOxc6moTvFTWfU0lPAX8f3lOErMwLVmwL-S--274O6fb2Do=">Longeveron Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric, and chronic aging-related conditions, today announced that it has licensed an issued US patent (12,168,028 B2) for a stem cell technology from the University of Miami. The composition of matter patent protects unique induced pluripotent derived cardiomyogenic cells that have widespread therapeutic indications for heart diseases. The stem/precursor cells protected by this patent are obtained by deriving cells that bear a cell surface receptor known as the GHRH-Receptor. These cells are uniquely able to differentiate into human cardiac muscle cells and have the potential to be safer than existing strategies to derive new cardiac heart muscle cells.

LGVN

Longeveron Licenses Issued US Patent For Stem Cell Technology From University Of Miami

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains Westamerica Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WABC#NASDAQ">WABC</a>) with a Market Perform and lowers the price target from $55 to $54.

WABC

Keefe, Bruyette & Woods Maintains Market Perform on Westamerica Bancorp, Lowers Price Target to $54

When financial expert Suze Orman gets a question from a concerned parent, she doesn't hold back — and she didn't mince words when responding to Michelle, a mom dealing with a $4,000 rent problem involving her son's girlfriend.
On a <a href="https://omny.fm/shows/suze-ormans-women-and-money/ask-kt-suze-anything-how-do-i-tell-my-son-that-his-girlfriend-is-sponging-off-him">recent episode</a> of the "Women &amp; Money" podcast, Orman laid out clear, tough-love advice for a listener who had found herself stuck in a difficult financial and emotional situation.
<h2 class="wp-block-heading">The Backstory: Rent Goes Unpaid and Savings Disappear</h2>
Michelle's email to Orman described a chain of events that began during the COVID-19 pandemic. Her son, now 24, struggled with remote college classes and eventually moved back home. After saving some money, he enrolled in a different college in the town where his sister had recently graduated. Michelle had purchased a house there as a <a href="https://www.benzinga.com/personal-finance/financial-advisors/25/07/46264474/dave-ramsey-says-real-estate-can-outperform-stocks-but-warned-that-higer-returns-dont-come-free">rental property</a> and let her son live in one of the rooms rent-free.
Don't Miss:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/mode-mobile-accredited-investor-offer">Accredited investors can claim pre-IPO shares of Mode Mobile for just $0.30</a>—with up to 120% bonus shares—before this Uber-style disruption hits the public markets</li>
<li>Named a TIME Best Invention and Backed by 5,000+ Users, Kara's Air-to-Water Pod Cuts Plastic and Costs — <a href="https://www.benzinga.com/money/americans-spend-1000-per-year-on-plastic-water-bottles-kara-pod-gives-you-clean-drinking-water-by-pulling-moisture-from-the-air">And You Can Invest At Just $6.37/Share</a></li>
</ul>
Things became more complicated when her son's girlfriend asked to move in. Michelle agreed and had her sign a lease, expecting her to pay rent. But the payments never came consistently. According to Michelle, the girlfriend only had sporadic jobs, borrowed money from Michelle's son and others, and now owes over $4,000 in back rent.
Michelle described her as someone with "big plans" but no steady income. Worse still, her son's once-healthy savings account had been drained while he was supporting her.
<h2 class="wp-block-heading">Suze's Response: ‘You Have 30 Days to Get Out'</h2>
Orman's response was swift and firm. "I would tell them they both have to leave," she said on the podcast. While she acknowledged how difficult that might be for a parent, she was clear that continuing to allow the situation would cause even more harm — especially to Michelle's son.
"I allowed your girlfriend to live here because I love you so much," Orman said, imagining what Michelle should tell her son. "But I don't love you enough to be down $4,000."
Trending: This AI-Powered Trading Platform Has 5,000+ Users, 27 Pending Patents, and a $43.97M Valuation — <a href="https://www.benzinga.com/money/finally-a-fully-automated-trading-platform-for-individual-investors?">You Can Become an Investor for Just $500.25</a>
She advised Michelle to give them both 30 days to move out and emphasized the need to be unwavering by saying something like: "You have to take responsibility that you are in a relationship with somebody who has been totally irresponsible. Therefore, if this is what you are choosing, then you have to choose to stick by her side and leave with her. You have 30 days to get out."
<h2 class="wp-block-heading">A Wake-Up Call for the Son</h2>
More than just about unpaid rent, Orman framed the situation as a pivotal moment in the young man's life. She warned that if Michelle didn't act now, the consequences could be long-term.
"If you don't kick your son into common sense gear," she said, "he's gonna possibly get this woman pregnant. He's possibly going to end up having to marry her. He's never going to have any money. That will be the biggest regret of his life."
Orman urged Michelle to be strict, even if her son pleads or promises to repay the money.&nbsp;
See Also: $100k+ in investable assets? <a href="https://www.benzinga.com/money/wiseradvisor-retirement-planning">Match with a fiduciary advisor for free to learn how you can maximize your retirement and save on taxes</a> – no cost, no obligation.
<h2 class="wp-block-heading">Tough Love, Long-Term Impact</h2>
While the advice may sound harsh, Orman says it's an act of love and protection. By putting boundaries in place now, Michelle may help her son avoid years of <a href="https://www.benzinga.com/25/05/45649052/couple-with-38k-salary-loses-300k-while-day-trading-dave-ramsey-asks-where-did-you-have-300k-that-you-could-lose">financial and emotional strain</a>.
"Think about that $4,000," Orman said. "Think about what you&#8217;re saving your son from, and you can do it."
Read Next: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $10.</a>
Image: Shutterstock

Personal Finance

Mom Says Her Son's Girlfriend Owes $4,000 In Back Rent — Suze Orman Tells Her To Kick Them Both Out: 'You Have 30 Days To Get Out'

Barclays analyst Jason Goldberg maintains Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) with a Underweight and raises the price target from $24 to $27.

Barclays Maintains Underweight on Regions Finl, Raises Price Target to $27

<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="900" height="600" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/21083157/Aux-0721-900x600-1.png" alt="" class="wp-image-16161" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/21083157/Aux-0721-900x600-1.png 900w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/21083157/Aux-0721-900x600-1-300x200.png 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/07/21083157/Aux-0721-900x600-1-768x512.png 768w" sizes="(max-width: 900px) 100vw, 900px" /></figure>
The air conditioner maker's low-price strategy has helped it win customers in China, while its OEM model has won over customers abroad
<h4 class="wp-block-heading">Key Takeaways:</h4>
<ul class="wp-block-list">
<li>Aux Electric achieved 20% revenue growth in 2024, outpacing rivals using a low-price strategy at home and OEM model overseas</li>
<li>The air conditioner maker's low-price strategy has won it market share, but has also resulted in quality concerns and significantly lower profit margins than its peers</li>
</ul>
The founder of air conditioner maker&nbsp;Aux Electric Co.&nbsp;is an Ox on the Chinese zodiac. That explains why Zheng Jianjiang chose to name his company Aux when he founded it more than three decades ago, choosing a rough homophone for Ox. The name signaled Zheng's ambition to imbue his company with traits of the Ox, including perseverance, audacity, and patience, according to Chinese tradition.
Such efforts may finally be bearing fruit as Zheng attempts to take his company public, offering investors a different type of air conditioner maker from several better-known larger rivals that are already listed. Last week, the company filed an&nbsp;<a href="https://www1.hkexnews.hk/app/sehk/2025/107548/documents/sehk25071600868.pdf">updated IPO listing document</a>&nbsp;with the Hong Kong Stock Exchange, as its plan was also&nbsp;<a href="http://www.csrc.gov.cn/csrc/c105984/c7571761/content.shtml">approved by</a>&nbsp;China's securities regulator, marking two major milestones for the listing.
The Hong Kong IPO plan is the latest twist in the company's tortuous journey to the capital markets. Aux first listed on China's thinly traded "New Third Board" in Beijing nearly a decade ago in 2016. But it delisted just a year later, partly due to thin liquidity and limited financing potential for companies listed in that market.
It then shifted its focus to China's more mainstream A-share market, planning to list on the Shanghai Stock Exchange. It kicked off that process in 2018, and in June 2023 finally completed an IPO counseling stage necessary for all listing candidates. But after completing that process, Aux shifted gears and set its sights on Hong Kong, filing its first application with the Hong Kong Stock Exchange in January this year. That application expired after six months, prompting the company to make its latest updated resubmission.
Aux has hired leading domestic investment bank CICC as its exclusive sponsor, indicating the listing should be relatively large, likely to raise up to $100 million or more.
<h4 class="wp-block-heading">Price advantage strategy</h4>
Aux is known for its aggressive low-pricing, credited as the force behind China's widely publicized air conditioner price wars in the early 2000s, as machine-cooled homes began to gain traction. In 2001, the company launched the provocative slogan "Dependable quality is the father, affordable pricing is the mother," as documented by local media.
The following year, Aux published a white paper breaking down one of its models to show its production costs. It used such analysis to accuse its competitors of overcharging, and then announced its own price cuts of 30% or more across its entire line of more than 40 products.
This strategy proved ruthless and effective. At a time when most air conditioners were priced around 3,500 yuan, or nearly $500, Aux's were often below 3,000 yuan. The strategy caught its competitors off guard, and positive consumer response established Aux's reputation overnight.
The company's relentless use of low prices has helped it establish itself as an affordable option, even if it hasn't challenged the dominance of China's three major players —&nbsp;Midea&nbsp;(0300.HK; 000333.SZ),&nbsp;Gree&nbsp;(000651.SZ) and&nbsp;Haier&nbsp;(6690.HK). According to research firm All View Cloud, air conditioner prices in China averaged 2,775 yuan online and 4,306 yuan at brick-and-mortar stores in 2024. Aux's online average price of just 2,207 yuan was the lowest among the top five manufacturers, while its offline average price was only 2,982 yuan.
The low-price strategy is serving the company well in China's current economic slowdown that has made consumers more price sensitive.
Still, Aux's revenue remains a fraction of giants like Haier and Gree, totaling 29.8 billion yuan ($4.15 billion) last year, or less than one-tenth of Haier's 401.6 billion yuan. Aux's revenue grew 20% year-on-year in 2024, more than double Haier's 8% and Midea's 9.4%, while Gree's revenue declined 7% for the year. That growth rate accelerated slightly in the first quarter of this year, as Aux's revenue rose 27% to 9.35 billion yuan from 7.36 billion yuan a year earlier.
The company's profits have also grown steadily over the last three years, rising 23% to 925 million yuan in the first quarter of 2025 from 752 million yuan a year earlier.
While the low-price strategy has won Aux market share, it also comes at a cost. The relentless focus on affordability has made it challenging for the company to maintain its product quality. A high-profile dispute in 2019 revolved around such quality issues, with Gree accusing multiple Aux models of failing energy efficiency and cooling power consumption tests.
But more importantly, the lower-price strategy has come at the expense of lower profit margins. Aux's air conditioner gross margin is significantly lower than its larger rivals, at just 19.2% last year, compared to Haier's 23.87%. While Midea and Gree don't break down margins by product, the former reported its smart home business, which includes air conditioners, was 29.97% last year. Meantime, Gree's manufacturing category, consisting largely of air conditioners, reached 32.55%.
Aux has been ramping up its international business to offset a slowing market at home, helping to fuel its relatively fast growth of recent years. Its exports grew 41% last year, and overseas sales accounted for 57.1% of its revenue total. The company touts such international sales as a major future growth driver.
However, the majority of Aux's overseas business consists of original equipment manufacturing (OEM), producing products carrying other companies' brands. Such a business model is notorious for its low profit margins, further explaining Aux's lower overall profitability compared to bigger rivals that have found more success by selling their own-branded models both at home and overseas.
At the end of the day, while strong sales growth is important, profitability is just as important, especially in a mature industry like air conditioners. To thrive over the longer term, Aux will need to find ways to better establish its own brand and compete on quality, not just price. Some recent moves are commendable, such as launching a high-end brand called Shin Flow in 2023, though that effort puts Aux in more direct competition with its larger rivals.
The company could also consider expanding into higher-margin central air conditioners that are widely used in commercial buildings but still relatively uncommon in homes. Aux derived over 87% of its revenue last year from household air conditioners, largely wall-mounted units. Increasing its focus on central air conditioners, which carried a profit margin of 30.4% compared to 19.25% for household units last year, would significantly improve its overall profitability.
For its international business, Aux will need to gradually transition away from simply serving as an OEM and work toward building its own brand recognition outside China. Only by balancing growth with profitability and quality can Aux Electric win over investors, showing it can produce air conditioners that are not only affordable but also dependable.
Benzinga Disclaimer: This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Asia

Equities

IPOs

Global

Opinion

China's Aux Electric Files For Hong Kong IPO

Keefe, Bruyette &amp; Woods analyst Wood Lay maintains Simmons First Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SFNC#NASDAQ">SFNC</a>) with a Market Perform and raises the price target from $21 to $22.

SFNC

Keefe, Bruyette & Woods Maintains Market Perform on Simmons First Ntl, Raises Price Target to $22

Barclays analyst Lauren Lieberman maintains PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) with a Equal-Weight and raises the price target from $132 to $144.

Barclays Maintains Equal-Weight on PepsiCo, Raises Price Target to $144

Keefe, Bruyette &amp; Woods analyst David Konrad maintains Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) with a Outperform and raises the price target from $29 to $30.

Keefe, Bruyette & Woods Maintains Outperform on Regions Finl, Raises Price Target to $30

Barclays analyst Adam Seiden maintains United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) with a Underweight and raises the price target from $565 to $620.

Barclays Maintains Underweight on United Rentals, Raises Price Target to $620

Keefe, Bruyette &amp; Woods analyst Christopher Mcgratty maintains Home BancShares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOMB#NYSE">HOMB</a>) with a Market Perform and raises the price target from $30 to $32.

HOMB

Keefe, Bruyette & Woods Maintains Market Perform on Home BancShares, Raises Price Target to $32

Keefe, Bruyette &amp; Woods analyst Kelly Motta maintains F N B (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNB#NYSE">FNB</a>) with a Outperform and raises the price target from $16.5 to $18.5.

Comments

Panbela Therapeutics

Panbela Therapeutics (PBLA) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO